Evaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus

被引:51
作者
Barber, Claire [2 ]
Herzenberg, Andrew [3 ]
Aghdassi, Ellie [4 ]
Su, Jiandong [4 ]
Lou, Wendy [5 ]
Qian, Gan [5 ]
Yip, Jonathan [4 ]
Nasr, Samih H. [6 ]
Thomas, David [7 ]
Scholey, James W. [8 ]
Wither, Joan [2 ,4 ,9 ]
Urowitz, Murray [2 ,4 ]
Gladman, Dafna [2 ,4 ]
Reich, Heather [8 ]
Fortin, Paul R. [1 ,2 ,4 ,10 ]
机构
[1] CHU Laval, Ctr Rech, CHUQ, Div Rheumatol,Dept Med, Quebec City, PQ G1V 4G2, Canada
[2] Univ Toronto, Dept Med, Div Rheumatol, Univ Hlth Network, Toronto, ON, Canada
[3] Univ Toronto, Dept Pathol, Univ Hlth Network, Toronto, ON, Canada
[4] Univ Toronto, Toronto Western Res Inst, Div Hlth Care & Outcome Res, Toronto, ON, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Mayo Clin, Div Anat Pathol, Rochester, MN USA
[7] Nephrocor, Long Isl City, NY USA
[8] Univ Toronto, Dept Med, Div Nephrol, Univ Hlth Network, Toronto, ON, Canada
[9] Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada
[10] Univ Laval, Quebec City, PQ, Canada
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2012年 / 7卷 / 05期
基金
加拿大健康研究院;
关键词
IMPROVING GLOBAL OUTCOMES; CHRONIC KIDNEY-DISEASE; LOGISTIC-REGRESSION; POSITION STATEMENT; ERYTHEMATOSUS; CLASSIFICATION; NEPHRITIS; LESIONS; GLOMERULONEPHRITIS; CRITERIA;
D O I
10.2215/CJN.02870311
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives The objective of this study was to determine the clinical significance of renal vascular lesions in lupus nephritis. Design, setting, participants, & measurements Renal vascular lesions defined as thrombotic microangiopathy, lupus vasculopathy, uncomplicated vascular immune deposits, and arterial sclerosis were evaluated in relation to renal and vascular morbidity and overall mortality. Results Biopsies from 161 patients revealed thrombotic microangiopathy (13), lupus vasculopathy (5), and arterial sclerosis (93). No renal vascular lesions were found in 24.8% of patients. At the time of biopsy, arterial sclerosis or lupus vasculopathy patients were older (arterial sclerosis=37.9 +/- 13.0 and lupus vasculopathy=44.4 +/- 8.9 versus controls=33.1 +/- 8.9 years, P < 0.05), and the mean arterial pressure was higher in all groups compared with controls. Nephritis subtype, activity indices, and proteinuria were similar between groups, estimated GFR was lower in arterial sclerosis (70.5 +/- 33.3 versus 84.5 +/- 26.6 ml/min per 1.73 m(2), P=0.03), and chronicity index (thrombotic microangiopathy=3.5, lupus vasculopathy=4.5, and arterial sclerosis=2.5) was higher in all renal vascular lesions subgroups versus controls (1.0, P < 0.05). In 133 patients with similar follow-up, the association between renal vascular lesions and vascular events was significant (Fisher exact test, P=0.002) and remained so after multivariate analysis (exact conditional scores test, P=0.04), where the difference between arterial sclerosis and uncomplicated vascular immune deposits was most noticeable (odds ratio [95% confidence interval]=8.35[0.98, 83.12], P=0.05). The associations between renal vascular lesions, renal outcomes, and death were not significant, likely because of insufficient power. Conclusions Renal vascular lesions are common in SLE patients with nephritis and may be associated with arterial vascular events. J Am Soc. Nephrol 7: 757-764, 2012. doi: 10.2215/CJN.02870311
引用
收藏
页码:757 / 764
页数:8
相关论文
共 22 条
  • [1] Exact inference for categorical data: recent advances and continuing controversies
    Agresti, A
    [J]. STATISTICS IN MEDICINE, 2001, 20 (17-18) : 2709 - 2722
  • [2] APPEL GB, 1994, J AM SOC NEPHROL, V4, P1499
  • [3] RENAL VASCULAR-LESIONS AS A MARKER OF POOR PROGNOSIS IN PATIENTS WITH LUPUS NEPHRITIS
    BANFI, G
    BERTANI, T
    BOERI, V
    FARAGGIANA, T
    MAZZUCCO, G
    MONGA, G
    SACCHI, G
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (02) : 240 - 248
  • [4] D'Agati V, 2007, HEPTINSTALLS PATHOLO, P518
  • [5] Renal vascular lesions in lupus nephritis
    Descombes, E
    Droz, D
    Drouet, L
    Grunfeld, JP
    Lesavre, P
    [J]. MEDICINE, 1997, 76 (05) : 355 - 368
  • [6] The development and initial validation of the systemic lupus international collaborating clinics American College of Rheumatology Damage Index for Systemic Lupus Erythematosus
    Gladman, D
    Ginzler, E
    Goldsmith, C
    Fortin, P
    Liang, M
    Urowitz, M
    Bacon, P
    Bombardieri, S
    Hanly, J
    Hay, E
    Isenberg, D
    Jones, J
    Kalunian, K
    Maddison, P
    Nived, O
    Petri, M
    Richter, M
    SanchezGuerrero, J
    Snaith, M
    Sturfelt, G
    Symmons, D
    Zoma, A
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (03): : 363 - 369
  • [7] Gladman DD, 2002, J RHEUMATOL, V29, P288
  • [8] Lost-to-follow-up study in systemic lupus erythematosus (SLE)
    Gladman, DD
    Koh, DR
    Urowitz, MB
    Farewell, VT
    [J]. LUPUS, 2000, 9 (05) : 363 - 367
  • [9] Greenland S, 2000, AM J EPIDEMIOL, V151, P531
  • [10] GRISHMAN E, 1988, MODERN PATHOL, V1, P235